Stoke Therapeutics Q3 Earnings Release: FDA Meeting Results Key Over Quarterly Loss
STOK Stoke Therapeutics Inc
$25.04 -2.57%
View chart & analysis → - 1Stoke Therapeutics Inc is approaching its third-quarter earnings release.
- 2The Street expects a third-quarter loss of $0.88 per share for Stoke Therapeutics Inc.
- 3Stoke Therapeutics Inc has completed patient enrollment for the Emperor clinical trial.
So what's the key point?
Stoke Therapeutics Inc is preparing to announce its third-quarter results. Experts expect a loss of approximately $0.88 per share.
Source Earnings Whispers · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.